Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants

Bibliographic Details
Main Authors:	Cha, Yoon Jin, Kim, Hye Ryun, Shim, Hyo Sup
Format:	Online
Language:	English
Published:	BioMed Central 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069800/

Similar Items

Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
by: Cha, Yoon Jin, et al.
Published: (2014)

CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma
by: An, Rong, et al.
Published: (2016)

Thyroid metastasis from lung adenocarcinoma with EML4-ALK rearrangement
by: Kawamoto, Hironori, et al.
Published: (2016)

Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
by: Marino, Federica Zito, et al.
Published: (2015)

SEC31A-ALK Fusion Gene in Lung Adenocarcinoma
by: Kim, Ryong Nam, et al.
Published: (2016)

Overview of ALK and ROS1 Rearranged Lung Cancer
by: Choi, Chang Min
Published: (2013)

ALK-rearranged squamous cell carcinoma of the lung
by: Takanashi, Yusuke, et al.
Published: (2015)

Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements
by: Wu, Shafei, et al.
Published: (2015)

The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy
by: Zhang, Ning-Ning, et al.
Published: (2014)

ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy
by: Incharoen, Pimpin, et al.
Published: (2016)

Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group
by: Kim, Hyojin, et al.
Published: (2014)

Clinical Characteristics and Outcomes of Patients with Primary Lung Adenocarcinoma Harboring ALK Rearrangements Detected by FISH, IHC, and RT-PCR
by: Wang, Jinghui, et al.
Published: (2014)

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
by: Iwama, Eiji, et al.
Published: (2014)

Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK
by: Damm-Welk, Christine, et al.
Published: (2016)

Rationale for co-targeting IGF-1R and ALK in ALK fusion positive lung cancer
by: Lovly, Christine M., et al.
Published: (2014)

Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
by: Mattsson, Johanna S. M., et al.
Published: (2016)

Spectrum of EGFR gene mutations and ALK rearrangements in lung cancer patients in Turkey
by: Sag, Sebnem Ozemri, et al.
Published: (2016)

Ceritinib for ALK-Rearrangement–Positive Non–Small Cell Lung Cancer
by: Nix, Nancy M., et al.
Published: (2015)

Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
by: Dagogo-Jack, Ibiayi, et al.
Published: (2016)

Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach
by: Yoon, Hyun Jung, et al.
Published: (2015)

Atypical Carcinoid Tumor with Anaplastic Lymphoma Kinase (ALK) Rearrangement Successfully Treated by an ALK Inhibitor
by: Nakajima, Masayuki, et al.
Published: (2016)

Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma
by: Gennatas, Spyridon, et al.
Published: (2013)

A lung adenocarcinoma patient with EGFR mutation in exon 18 and ALK-rearrangement who treated with erlotinib and crizotinib
by: Mehmet Artaç, et al.
Published: (2018-08-01)

Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications
by: Hainsworth, John D., et al.
Published: (2016)

Correction: Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
by: Zito Marino, Federica, et al.
Published: (2015)

Frequencies of ALK rearrangements in lung adenocarcinoma subtypes: a study of 2299 Chinese cases
by: Yu, Yongfeng, et al.
Published: (2016)

ALK and NSCLC: Targeted therapy with ALK inhibitors
by: Hallberg, Bengt, et al.
Published: (2011)

Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
by: Ahn, Jin Woo, et al.
Published: (2014)

Cytologic Features of ALK-Positive Pulmonary Adenocarcinoma
by: Ha, Seung Yeon, et al.
Published: (2013)

A Screening Method for the ALK Fusion Gene in NSCLC
by: Murakami, Yoshiko, et al.
Published: (2012)

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation
by: Miyanaga, Akihiko, et al.
Published: (2013)

A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
by: Kashima, Jumpei, et al.
Published: (2016)

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition
by: KOGITA, AKIHIRO, et al.
Published: (2014)

Accurate and Economical Detection of ALK Positive Lung Adenocarcinoma with Semiquantitative Immunohistochemical Screening
by: Zhou, Jianya, et al.
Published: (2014)

Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
by: Brcic, Luka, et al.
Published: (2016)

Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung
by: Doval, DC, et al.
Published: (2015)

Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease
by: Lawrence, Kasey, et al.
Published: (2015)

A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
by: Tanaka, Hisashi, et al.
Published: (2012)

Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes
by: Ninomiya, Hironori, et al.
Published: (2013)

Frequency of EGFR Mutation and EML4-ALK fusion gene in Arab Patients with Adenocarcinoma of the Lung
by: Shafik Hanan Ezzat
Published: (2015-06-01)